Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5395-5404
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5395
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5395
Table 3 Side effects of radiotherapy combined with PPV-DC-CTL immunotherapy
Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
Constitutional symptom | ||||
Fever | 6 | 0 | 0 | 0 |
Tumor pain | 0 | 0 | 0 | 0 |
Rash | 2 | 0 | 0 | 0 |
Diarrhea | 0 | 0 | 0 | 0 |
Respiratory | ||||
Dyspnea | 0 | 0 | 0 | 0 |
Hypoxia | 0 | 0 | 0 | 0 |
Neurological | ||||
CNS cerebrovascular ischemia | 0 | 0 | 0 | 0 |
Blood/bone marrow | ||||
Anemia | 2 | 0 | 0 | 0 |
Neutropenia | 0 | 1 | 0 | 0 |
Lymphocytopenia | 0 | 0 | 0 | 0 |
Thrombocytopenia | 3 | 0 | 0 | 0 |
Metabolic and laboratory | ||||
AST elevation | 0 | 0 | 0 | 0 |
ALT elevation | 0 | 0 | 0 | 0 |
Scr elevation | 0 | 0 | 0 | 0 |
BUN elevation | 0 | 0 | 0 | 0 |
- Citation: Shen J, Wang LF, Zou ZY, Kong WW, Yan J, Meng FY, Chen FJ, Du J, Shao J, Xu QP, Ren HZ, Li RT, Wei J, Qian XP, Liu BR. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 2017; 23(29): 5395-5404
- URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5395.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i29.5395